Enzyme replacement therapy for gaucher disease: Skeletal responses to macrophage-targeted glucocerebrosidase

Pediatrics

Volumn 96, Issue 4 I, 1995, Pages 629-637

  Rosenthal, D I ^a   Doppelt, S H ^a   Mankin, H J ^a   Dambrosia, J M ^a   Xavier, R J ^a   McKusick, K A ^a   Rosen, B R ^a   Baker, J ^a   Niklason, L T ^a   Hill, S C ^a   Miller, S P F ^a   Brady, R O ^a   Barton, N W ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

bone marrow; combined cortical thickness; enzyme replacement therapy; Gaucher disease; macrophage targeted glucocerebrosidase; trabecular bone density

Indexed keywords

ALGLUCERASE; GLUCOSYLCERAMIDASE;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW CELL; BONE MASS; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFICACY; ENZYME REPLACEMENT; FEMALE; GAUCHER DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LIPID COMPOSITION; MALE; MUSCLE INJURY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BONE AND BONES; BONE DENSITY; BONE MARROW; CHILD; DRUG DELIVERY SYSTEMS; FEMALE; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HUMAN; LIPIDS; MALE;

EID: 0029155493     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)